Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Metabolic Dysfunction-Associated Steatohepatitis – Geographic Focus: China – Nonalcoholic Steatohepatitis – China In-Depth (China)
Nonalcoholic steatohepatitis (NASH) is a chronic illness that induces significant and sometimes fatal liver fibrosis; it is one of the primary causes of liver transplantation. In China, where the…
Metabolic Dysfunction-Associated Steatohepatitis – Epidemiology – Epidemiology Dashboard
Clarivate Epidemiology’s coverage of NASH comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the total NASH prevalent cases for each country, as…
Metabolic Dysfunction-Associated Steatohepatitis – Epidemiology – Extrapolated Worldwide Coverage
Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key non-alcoholic steatohepatitis patient populations, covering 171…
Hepatitis B Virus – Geographic Focus: China – Hepatitis B Virus – China In-Depth – China
The prevalence of HBV is a major public health concern in China. Patients chronically infected with HBV are at high risk of developing hepatic cirrhosis and hepatocellular carcinoma. The majority…
Nonalcoholic Steatohepatitis | Treatment Algorithms: Claims Data Analysis | US | 2023
Nonalcoholic steatohepatitis (NASH) has the potential to be a large and lucrative therapy market owing to the prevalence of the disease and the lack of approved agents. Patients with NASH are at…
Non-Alcoholic Steatohepatitis (NASH) | Disease Landscape and Forecast | G7 | 2022
The market for NASH, a severe form of nonalcoholic fatty liver disease (NAFLD), offers substantial commercial opportunity to drug developers owing to the lack of approved agents and the disease’s…
